Dogwood State Bank (DSBX)
OTCMKTS
· Delayed Price · Currency is USD
14.19
-0.01 (-0.07%)
Apr 25, 2025, 4:00 PM EDT
Dogwood State Bank Revenue
Dogwood State Bank had revenue of $25.27M in the quarter ending March 31, 2025, with 90.87% growth. This brings the company's revenue in the last twelve months to $79.46M, up 59.42% year-over-year. In the year 2024, Dogwood State Bank had annual revenue of $67.43M with 38.97% growth.
Revenue (ttm)
79.46M
Revenue Growth
+59.42%
P/S Ratio
3.40
Revenue / Employee
2.41M
Employees
33
Market Cap
269.79M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 67.43M | 18.91M | 38.97% |
Dec 31, 2023 | 48.52M | 28.89M | 147.13% |
Dec 31, 2020 | 19.63M | 8.42M | 75.04% |
Dec 31, 2019 | 11.22M | 3.30M | 41.74% |
Dec 31, 2016 | 7.91M | 734.00K | 10.22% |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Federal National Mortgage Association | 31.05B |
Federal Home Loan Mortgage | 23.44B |
Central Bancompany | 883.13M |
First National of Nebraska | 1.89B |
Mechanics Bank | 381.61M |
Copper Property CTL Pass Through Trust | 100.38M |
First National Bank Alaska | 194.47M |
W.T.B. Financial | 323.36M |
Dogwood State Bank News
- 10 days ago - Dogwood State Bank Reports Record Earnings in First Quarter of 2025 - PRNewsWire
- 6 weeks ago - Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward - GlobeNewsWire
- 3 months ago - Dogwood State Bank Reports Fourth Quarter and Full Year 2024 Results - PRNewsWire
- 3 months ago - Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025 - GlobeNewsWire
- 6 months ago - Dogwood Therapeutics Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024 - GlobeNewsWire
- 6 months ago - Dogwood State Bank Reports Third Quarter 2024 Results and Successful Integration of Community First - PRNewsWire
- 9 months ago - Dogwood State Bank Reports Higher Second Quarter 2024 Earnings Reflecting Strong Operating Momentum Heading into Community First Acquisition - PRNewsWire